Literature DB >> 34650655

Factors impacting on diabetes knowledge, medication adherence and glycemic control among adult diabetics visiting a county teaching and referral hospital in Kenya: a cross-sectional study.

Faith Machocho Mwangasha1, David Gitonga Nyamu2, Lucy Jemutai Tirop2.   

Abstract

INTRODUCTION: optimal management of diabetes involves interplay between patients' understanding of their disease and medication adherence, which would eventually influence glycemic control. However, there is scant published literature on the interconnection of patient related factors that impact on optimal management of diabetes in resource-limited settings such as Kenya.
METHODS: a hospital based cross-sectional survey involving 270 freely consenting adult diabetics investigated the interconnection between diabetes knowledge, medication adherence and glycemic control. Data on the patient´s knowledge and medication adherence was collected using validated tools whilst glycemic control was evaluated using the patients' glycated haemoglobin values. Data analysis was carried out using STATA version 13 statistical software, employing the chi square test for association and simple linear regression for prediction, with p ≤0.05 considered significant.
RESULTS: participants´ level of knowledge on diabetes was significantly associated with the academic achievement (p=0.001), while their medication adherence was significantly associated with family support (p=0.001) and duration of disease since diagnosis (p=0.019). On linear regression, family support occasioned by the nature of participants' household setup, had a strong positive correlation [r=0.99 (CI 0.60-1.00)] with optimal glycemic control.
CONCLUSION: family support is an important determinant of medication adherence and optimal glycemic control among diabetic patients. Clinicians should team up with family members of diabetic patients for optimal glycemic control. Copyright: Faith Machocho Mwangasha et al.

Entities:  

Keywords:  Diabetes knowledge; glycated haemoglobin; glycemic control; medication adherence

Mesh:

Substances:

Year:  2021        PMID: 34650655      PMCID: PMC8490163          DOI: 10.11604/pamj.2021.40.5.21848

Source DB:  PubMed          Journal:  Pan Afr Med J


Introduction

Scientific background: the optimal management of chronic illnesses such as diabetes is influenced by environmental, patient-related, health system and disease-related factors [1]. As the patient is the key determinant of the success of treatment, patient-related factors, though complex, form the backbone of optimal diabetes control [2]. Among these patient related factors are diabetes knowledge, medication adherence, economic and psychosocial factors. Patient knowledge comprises the extent of the patients´ understanding of diabetes as to what the disease is, its complications and both its pharmacological and non-pharmacological management [3]. Patient knowledge has been shown to be dependent on socio-demographic factors such as age, sex and literacy level [3], the ability to access information as well as the accuracy and presentation of medical information [4]. Medication adherence entails the willingness and the ability of the patient to comply with the prescribed treatment regimen [5]. Non-adherence may be classified into two levels: intentional and non-intentional. Intentional non-adherence originates from the patients´ choice not to adhere to a drug regimen while non-intentional non-adherence is occasioned by factors beyond the patient´s control such as unavailability of drugs from the local pharmacy [6]. Non-adherence to medication also includes a deliberate choice on the patients´ part not to even start on a treatment regimen [5]. Rationale: patient related factors, which are the most important determinants of the success of diabetes treatment, have not been adequately evaluated in a low resource setting such as Kenya. Study objectives: the present study determined and explored the interplay between patient knowledge, medication adherence and glycemic control among adult diabetics in a low resource setting.

Methods

The study design was a cross-sectional survey conducted at the Diabetes Outpatient Clinic in Coast Teaching and Referral Hospital (CTRH) in Mombasa, Kenya. The hospital is the largest teaching and referral public hospital in Mombasa County with a bed capacity of 1000. The study population included adult (age ≥ 18 years) patients, attending the clinic at hospital, who had been medication for over two months. Both sexes were included in the study. Pregnant women, patients with mental illness or liver disorders were excluded from the study. Ethical approval for the study was obtained from both the Kenyatta National Hospital-University of Nairobi Ethics Review Committee (KNH-ERC/A/259) and the CTRH Ethics Review Committee (ERC-CGH/MSc/VOL.1/62). Data on glycated haemoglobin (HbA1c), which correlated with glycemic control, was extracted from patient files, whilst that on socio-demographics and patient-related factors was collected using pre-designed study questionnaires. The target sample size was 270 patients and was estimated via the Cochrane formula applying a desired precision of 0.05 and medication adherence level of 0.5 [7]. Convenient sampling was used until the sample size was achieved. Missing data: where HbA1c data was unavailable, fasting blood sugar and post prandial blood sugar values were used to evaluate glycemic control. Bias: confounding factors such as co-morbidities and intrinsic genetic factors which may influence glycemic control were not accounted for in the study. Patient Knowledge was investigated using a revised and validated Diabetes Knowledge Test (DKT) adopted from Michigan Diabetes Research Center [8]. The DKT comprise of twenty statements about diabetes to which the participant could respond true (1 mark), false (1 mark) or don´t know (0 mark). The respondent´s final score was expressed out of 20 then computed as a percentage. Medication Adherence levels were assessed by the use of the Morisky Medication Adherence Scale (MMAS), adopted from the International Journal of Clinical and Health Psychology [9]. The respondent´s level of adherence was measured by the use of a series of eight questions, each with structured responses resembling the Likert Scale of 1-5 attached to a score. The score was totaled out of 40 and expressed as a percentage. The higher scoring patient was deemed to be more adherent than the lower scoring patient. The nature of non-adherence, whether intentional or non-intentional, was determined by the nature of responses given. The DKT and MMAS scores were then correlated with the presumed determinants of patient knowledge (participants´ age, sex, economic capacity and education level) and medication adherence (monthly income, disease duration, household set up) using the Chi square test for association. The determinants shown to have a significant association with knowledge levels or medication adherence among the participants were then correlated to glycemic control using simple linear regression.

Results

Socio-demographic characteristics of the participants: the socio-demographic characteristics of 270 patients who participated in the study are presented in Table 1. The study participants had a slight male preponderance (53.7%) with the majority being middle-aged adults of 41-50 years (29.3%) and 31-40years (19.3%). The middle-income bracket, (KES 20001-30000), typified 32.2% of the participants as the modal income. Most of the participants were of either secondary (46.2%) or tertiary education levels (43.3%). The majority of the participants were married (39.2%) and lived with their families (64.4%) (Table 1).
Table 1

socio-demographic characteristics of the participants

VariableCategorynPercentage (%)
Gender Male 150 53.7
Female12046.3
Age(Years) 20-30259.2
31-405219.3
41-50 79 29.3
51-606423.7
+605018.5
Marital Status Single3814.1
Cohabiting269.6
Married 106 39.2
Separated3914.4
Divorced218.1
Widowed3814.1
Missing20.5
Medical Insurance Yes13951.5
Partial217.8
No 110 40.7
Monthly Income (Kenya Shillings) ≤10000217.8
10001-200003211.8
20001-30000 87 32.2
30001-400005219.3
40001-500004315.9
+500003513.0
Employment Status Formally Employed 103 38.1
Self-employed9635.5
Unemployed3412.6
Pensioned3011.2
Job-seeking72.6
Religious Affiliation Staunch 77 28.5
Moderate9133.7
Basic7728.5
Other228.5
Missing31.1
Highest Education level Primary176.7
Secondary 125 46.2
Tertiary11743.3
Informal93.3
Missing20.4
Living Arrangement With Family 174 64.4
With Partner2710
With Friends31.1
With Colleagues41.5
Alone6223
socio-demographic characteristics of the participants Clinical characteristics of the participants: most of the participants (58.9%) reported 6-10 years of disease duration (Table 2). Diabetes support group participation was low among the study population, at only 21.5%. Optimal glycemic control (HbA1c <7%) was reported among 67.8% of the participants (Table 2).
Table 2

clinical characteristics of the participants

VariableCategoryNPercentage (%)
Disease duration, years ≤ 56122.6
6-10 159 58.9
11-154717.4
16+10.4
Missing20.7
In DM Support Group Yes5821.5
No 212 78.5
Optimal Glycemic Control Yes 183 67.8
No8431.1
Missing31.1
HbA1c Range (%) 6-6.56022.2
>6.5-7 80 29.6
>7-8207.4
>8-95118.8
>9134.8
Other*4315.9
Missing31.1

Key: DM=Diabetes Mellitus and HbA1c=Glycosylated haemoglobin*Where HbA1c values were unavailable Fasting Blood Sugar and Post Prandial Blood Sugar values were used to establish glycemic control. †43 patients (15.9%) were deemed to have optimal glycemic control via Fasting Blood Sugar and Post Prandial Blood Sugar values.

clinical characteristics of the participants Key: DM=Diabetes Mellitus and HbA1c=Glycosylated haemoglobin*Where HbA1c values were unavailable Fasting Blood Sugar and Post Prandial Blood Sugar values were used to establish glycemic control. †43 patients (15.9%) were deemed to have optimal glycemic control via Fasting Blood Sugar and Post Prandial Blood Sugar values. DKT score: the average score of the participants in the DKT was 42.7%. Most of the participants had an average knowledge level of diabetes, with 44.8% of them scoring between 31-50% in the test. Almost a third (29.6%) of the participants had DKT scores of 51-75%, representing an above average knowledge level. A small proportion of 6.6% and 18.5% of the participants had DKT scores of > 75% (excellent level of knowledge) and ≤ 30% (low level of knowledge), respectively. Among participants perceived to have excellent diabetes knowledge (DKT score > 75%), majority had attained tertiary level of education at 88.9% (Table 3). Conversely, the majority of participants scoring the lowest on the DKT (≤ 30%) had attained primary or secondary education. Table 4 elucidates some DKT responses by this lowest scoring group.
Table 3

DKT score vs gender and education level of respondents

VariableCategorynPercentage (%)
DKT ≤30 Gender
Male 27 54
Female2346
Highest Education Level
Informal918
Primary1734
Secondary 22 44
Tertiary24
DKT +75 Gender
Male 10 55.6
Female844.4
Highest Education Level
Informal00
Primary00
Secondary211.1
Tertiary 16 88.9
Table 4

most poorly done questions on diabetes knowledge test

VariableCategorynPercentage
Glycosylated hemoglobin (HbA1c) is a test that measures your average blood glucose level in the past week. Correct 5 10
Wrong3060
Don’t know1515
Urine testing and blood testing are both equally as good for testing blood glucose. Correct 3 6
Wrong4080
Don’t know714
Wearing shoes a size bigger helps prevent foot ulcers. Correct 2 4
Wrong4590
Don’t know36
High blood glucose may be caused by too much insulin. Correct 1 2
Wrong4692
Don’t know36
If you take your morning insulin and skip breakfast your blood glucose levels normally decrease. Correct 2 4
Wrong4590
Don’t know36
Attending your doctor’s appointments will stop from you getting diabetes complications. Correct 1 2
Wrong4896
Don’t know12

The number of correct responses for each variable is highlighted.

DKT score vs gender and education level of respondents most poorly done questions on diabetes knowledge test The number of correct responses for each variable is highlighted. MMAS score: slightly over half (56.6%) of the study participants recorded an above average level of medication adherence (MMAS-8 scores above 50%). Lower levels of adherence, MMAS-8 scores of 31-50% and ≤ 30% were occasioned by 31.5% and 11.9% of the participants, respectively. Table 5 profiles the treatment adherence patterns with possible determinants namely participant income, disease duration and living arrangement.
Table 5

treatment adherence patterns of the participants relative to income, disease duration and living arrangement

VariableCategoryNPercentage (%)
MMAS-8 score ≤30 (Least Adherent) Monthly Income (KES)
≤10000 20 62.5
10001-2000039.4
20001-3000013.1
30001-4000013.1
40001-5000013.1
+50000618.8
Disease Duration (Years)
≤ 5 20 62.5
6-1039.4
11-15928.1
Living Arrangement
With Family412.5
Partner1031.3
Alone 18 56.2
MMAS-8 score +75 (Most Adherent) Monthly Income (KES)
≤1000000.0
10001-2000026.25
20001-3000039.4
30001-40000515.6
40001-5000026.25
+50000 20 62.5
Disease Duration (Years)
≤ 5515.6
6-10515.6
11-15 22 68.8
Living Arrangement
With Family 15 46.9
Partner1031.2
Alone721.9

Key: MMAS-8=Morisky Medication Adherence Scale version 8, KES= Kenya Shillings the highest values are highlighted in each category.

treatment adherence patterns of the participants relative to income, disease duration and living arrangement Key: MMAS-8=Morisky Medication Adherence Scale version 8, KES= Kenya Shillings the highest values are highlighted in each category. Associations between the predictor factors and the first outcome variables: the associations between the participants´ socio-demographic characteristics and diabetes knowledge and treatment adherence were determined using the chi square test. There was a statistically significant association between the participants´ knowledge level and their literacy level (p=0.001). The effect of participants´ age (p=0.533) and disease duration (p=0.605) on their knowledge levels were non-significant. On the contrary, disease duration (p=0.019) and household setup (p=0.001) were significantly associated with treatment adherence. The relationship between participants´ monthly income and treatment adherence was not substantial (p=0.206). Correlation between the patient socio-demographics and clinical characteristics with optimal glycemic control: the correlation between the predictors associated with the aforementioned patient factors and optimal glycemic control was computed using simple linear regression. The education level of the participants showed only a weak positive correlation [r=0.23 (CI -0.94-0.98)] with optimal glycemic control. The disease duration had a weak negative correlation [r=-0.22 (CI -0.97-0.94)] to optimal glycemic control. Notably, the nature of household setup posted a strong positive correlation [r=0.99 (CI 0.60-1.00)] to optimal glycemic control among study participants.

Discussion

The number of participants with optimal glycemic control was higher than that observed in similar studies; for instance a study done in Kenyatta National Hospital, the largest referral hospital in Kenya, where optimal glycemic control was recorded by 36.9% of the sample population [7]. This observation may be indicative of improvement in patient management. Among the fifty participants recording the lowest DKT scores (≤ 30%), questions on diabetes complications and insulin therapy were the most poorly done. Notably, the deficiency of patients´ knowledge on insulin therapy has been reported. A recent study by Kituzi et al. [10] revealed that only 53.4% of adult diabetics visiting a Kenyan referral hospital correctly performed the all steps of the insulin injection technique as described by the American Diabetes Association. The participants´ level of income and disease duration were positively correlated with medication adherence. High-income earners (KES+50000) and those with longer disease duration (11-15 years) dominated the MMAS-8 score > 75% bracket. Participants living with their families recorded higher adherence scores than those living alone. These findings are consistent with those reported from related studies [7, 11, 12]. Probably higher income may enhance affordability of medication [7], whilst patients with longer duration of disease are more likely to interact better with their health care providers, understand their treatment plans, and become more aware of their diseases [12]. Patients were shown to value family support, which perhaps involved reminders of medication times, preparation of healthy meal plans and participation in exercise sessions, towards medication adherence often with positive results [11]. Among the study participants attaining the lowest MMAS-8 scores (≤ 30%), 55% expressed non-adherence occasioned by factors such as forgetfulness, implicative of non-intentional non-adherence. The weak correlation of participants´ education level with optimal glycemic control, implied that whilst patient knowledge is essential, there may be other intervening factors affecting actual glycemic control. Factors that promote self-monitoring, diet and exercise adherence must also be taken into account [13]. The weak negative correlation of disease duration to optimal glycemic control has been reported previously [14]. The nature of household setup was a strong determinant of glycemic control, with those participants living with their families recording lower HbA1c values. As stated earlier, patients greatly valued family support towards medication adherence and overall glycemic control [15]. Limitations: while we appreciate that the strength of the present study is use of validated data collection tools, a potential limitation is the inclusion of patients primarily from a referral hospital in the coastal region of Kenya as a representation of the general Kenyan population. Additionally, as common with cross-sectional studies involving direct interviews, patients could have understated or overstated their experiences. Generalisability: the generalisability of the study findings elsewhere in Kenya warrants further investigation. Notably, the study population has unique cultural practices and norms compared to the rest of the country.

Conclusion

Patients´ literacy level, a determinant for knowledge showed a weak positive correlation to optimal glycemic control among the study participants. Living within a family setup was significantly associated with better treatment adherence and positively correlated to optimal glycemic control. Involvement of family members in the diabetic patients´ hospital visits and treatment plans should be encouraged.

What is known about this topic

Successful management of diabetes mellitus is influenced by a multitude of factors; environmental, health system, patient-related and disease-related factors; Patient related factors form the backbone for optimal management of diabetes mellitus; Among these patient related factors are diabetes knowledge, medication adherence, economic and psychosocial factors.

What this study adds

The current study elucidates the interplay of factors between patient knowledge, medication adherence and glycemic control among adult diabetics in a low resource setting; Education level, a determinant for patient knowledge, showed a weak positive correlation to optimal glycemic control; Family support, a determinant for medication adherence, showed a strong positive correlation to optimal glycemic control.
  13 in total

Review 1.  A metasynthesis of factors affecting self-management of chronic illness.

Authors:  Dena Schulman-Green; Sarah S Jaser; Chorong Park; Robin Whittemore
Journal:  J Adv Nurs       Date:  2016-01-19       Impact factor: 3.187

2.  Validation of the Revised Brief Diabetes Knowledge Test (DKT2).

Authors:  James T Fitzgerald; Martha M Funnell; Robert M Anderson; Robin Nwankwo; R Brent Stansfield; Grecthen A Piatt
Journal:  Diabetes Educ       Date:  2016-01-14       Impact factor: 2.140

3.  Defining medication adherence in individual patients.

Authors:  Alan Morrison; Melissa E Stauffer; Anna S Kaufman
Journal:  Patient Prefer Adherence       Date:  2015-07-01       Impact factor: 2.711

4.  Adherence to Long-Term Therapies and Beliefs about Medications.

Authors:  Abdullah Alhewiti
Journal:  Int J Family Med       Date:  2014-02-13

5.  Diabetes knowledge and utilization of healthcare services among patients with type 2 diabetes mellitus in Dhaka, Bangladesh.

Authors:  Md Kaoser Bin Siddique; Sheikh Mohammed Shariful Islam; Palash Chandra Banik; Lal B Rawal
Journal:  BMC Health Serv Res       Date:  2017-08-22       Impact factor: 2.655

6.  Medications Adherence and Associated Factors among Patients with Type 2 Diabetes Mellitus in the Gaza Strip, Palestine.

Authors:  Aymen Elsous; Mahmoud Radwan; Hasnaa Al-Sharif; Ayman Abu Mustafa
Journal:  Front Endocrinol (Lausanne)       Date:  2017-06-09       Impact factor: 5.555

Review 7.  A Systematic Review: Family Support Integrated with Diabetes Self-Management among Uncontrolled Type II Diabetes Mellitus Patients.

Authors:  Rian Adi Pamungkas; Kanittha Chamroonsawasdi; Paranee Vatanasomboon
Journal:  Behav Sci (Basel)       Date:  2017-09-15

8.  Does knowledge on diabetes management influence glycemic control? A nationwide study in patients with type 1 diabetes in Brazil.

Authors:  Marilia Brito Gomes; Deborah Conte Santos; Marcela H Pizarro; Bianca Senger V Barros; Laura G Nunes de Melo; Carlos A Negrato
Journal:  Patient Prefer Adherence       Date:  2018-01-04       Impact factor: 2.711

9.  Patient involvement in healthcare professional practice - a question about knowledge.

Authors:  Tine Aagaard
Journal:  Int J Circumpolar Health       Date:  2017       Impact factor: 1.228

10.  Psychometric properties of the eight-item Morisky Medication Adherence Scale (MMAS-8) in a psychiatric outpatient setting.

Authors:  Carlos De Las Cuevas; Wenceslao Peñate
Journal:  Int J Clin Health Psychol       Date:  2014-12-25
View more
  1 in total

Review 1.  Peer support and social networking interventions in diabetes self-management in Kenya and Uganda: A scoping review.

Authors:  Habil Otanga; Brian Semujju; Lynn Mwaniki; Justus Aungo
Journal:  PLoS One       Date:  2022-09-26       Impact factor: 3.752

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.